Status:
RECRUITING
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Malignant Neoplasms
Hereditary Neoplastic Syndromes
Eligibility:
All Genders
2+ years
Brief Summary
Selected individuals suspected of having or with prior biopsy proof of malignant disease will be seen in the Urologic Oncology Branch, NCI. Blood samples may be collected at the time of the initial vi...
Detailed Description
Background Kidney, prostate, bladder, testis and penile cancer account for 22% of cancers diagnosed in the United States and are responsible for 10% of cancer deaths each year in the U.S. Understandi...
Eligibility Criteria
- INCLUSION CRITERIA:
- Individuals with biopsy-proven malignant disease
- Individuals suspected of having a malignant disease
- Individuals who have or are suspected of having an inherited genitourinary malignant disorder
- Participants must be >= 2 years of age
- A relative (related by blood) of an individual with a confirmed or suspected diagnosis of a malignant disease or an inherited genitourinary malignant disorder.
- All participants and parents/guardians, for children younger than 18 years of age, must sign an informed consent document indicating their understanding of the investigational nature and the risks of this study before any protocol related studies are performed.
EXCLUSION CRITERIA:
-Individuals whose co-morbidities preclude surgical intervention.
Key Trial Info
Start Date :
March 12 1998
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
5950 Patients enrolled
Trial Details
Trial ID
NCT00026884
Start Date
March 12 1998
Last Update
April 14 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892